Key Takeaways
- SNOW shares declined 11.8% Thursday, sliding from $149.99 to approximately $132 per share
- Volume surged to 152% above typical levels, with more than 15 million shares traded
- Class-action securities fraud lawsuit deadline looming on April 27, 2026 increases investor anxiety
- Reports of customer data compromises tied to third-party integrator vulnerabilities surfaced
- Widespread software sector decline fueled by concerns over AI agents replacing traditional SaaS platforms
Thursday proved to be a punishing session for Snowflake (SNOW) shareholders. The cloud data platform provider saw its shares crater 11.8%, tumbling from $149.99 down to approximately $132, while trading activity exploded to more than 150% above normal daily volumes. When you see volume spikes of that magnitude, multiple catalysts are typically at work — and that’s exactly what happened here.
This wasn’t a single-headline story. Rather, it was a convergence of negative factors hitting simultaneously.
Legal troubles continue to cast a shadow. Several law firms have issued investor notifications related to a securities fraud class-action lawsuit spanning June 2023 through February 2024. With the lead plaintiff deadline set for April 27, 2026, these alerts are resurfacing in news cycles, keeping legal uncertainties front and center for shareholders.
Meanwhile, new security concerns have emerged. Reports indicate customer data was compromised through vulnerabilities at a third-party integration partner. While Snowflake’s core infrastructure wasn’t directly breached, the company acknowledged detecting “unusual activity” — exactly the kind of language that makes institutional investors nervous.
AI Fears Trigger Broader Software Rout
Snowflake’s decline didn’t happen in isolation. Thursday witnessed a punishing selloff across the entire software landscape, driven by mounting concerns that AI agents could diminish or eliminate demand for conventional enterprise software solutions. Cloudflare (NET) plummeted roughly 12%, ServiceNow (NOW) shed approximately 7%, and Snowflake got swept up in the same downdraft.
The underlying thesis is simple but threatening: if intelligent AI agents can automate the workflows currently handled by SaaS platforms, those platforms face demand erosion. This repricing narrative has been percolating for months, and Thursday appeared to be a tipping point for investor sentiment.
Adding fuel to the bearish fire, insider transactions have tilted heavily toward selling. During the past three months, company insiders have offloaded roughly $108 million in shares. Director Michael Speiser reduced his holdings by more than 62% in early March. EVP Christian Kleinerman sold 10,000 units in February. The scale and timing of these sales haven’t gone unnoticed by the market.
The Optimistic View Remains Intact
Despite Thursday’s bloodbath, analyst sentiment hasn’t collapsed. The consensus maintains a “Moderate Buy” rating with an average price target hovering around $249.62 — implying nearly 100% upside from current levels.
The optimistic case hinges on Cortex AI, Snowflake’s native AI platform, and the expanding ecosystem of developers building applications on top of it. Healthcare technology firm Penguin AI exemplifies this trend, constructing workflow solutions directly within the Snowflake AI Data Cloud environment.
Recently, Snowflake rolled out Iceberg V3 compatibility, a technical enhancement that strengthens data interoperability and potentially addresses enterprise concerns about platform dependency.
On the fundamental front, revenue momentum remains robust. Last quarter, Snowflake delivered $1.28 billion in revenue, representing 30.1% year-over-year growth and exceeding analyst projections. Earnings per share reached $0.32, surpassing the $0.27 consensus estimate.
The challenge lies in profitability metrics. The company continues operating with a negative net margin of 28.43% and a negative return on equity of 50.61%. Year-to-date, SNOW has declined over 31%, trading substantially below both its 50-day moving average of $169.90 and 200-day moving average of $213.12.
Rosenblatt Securities maintained its Buy rating with a $275 price objective in late February. DA Davidson held its Buy stance but reduced its target from $300 to $250. TD Cowen similarly maintained its rating while adjusting its target from $270 to $255.


